Furthermore, our group has demonstrated increased immunoreactivity for ET-1 in endothelial cells within colorectal liver metastases compared with surrounding vessels (Shankar et al, 1998), suggesting that ET-1 may be involved in modulation of tumour blood flow, known to be altered in liver metastases. Here, EDN1 is linked to neoplasm.